Clinical Trial

VR Therapies for IBD

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Through a pilot randomized controlled trial (RCT), the aim is to test the clinical impact and feasibility of a AI-enhanced Virtual Reality (VR) Cognitive Behavioral therapy (CBT) program versus distraction VR among patients with inflammatory bowel disease (IBD) and anxiety. It is hypothesized that using VR/AI CBT may reduce anxiety and IBD symptoms, leading to improved overall physical, psychological, and social functioning when compared to distraction VR.
Trial Details
NCT Number NCT07590518
Lead Sponsor Brennan Spiegel
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Chicago
Conditions Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn Disease (CD), Anxiety
Enrollment 76 participants
Start Date 2026-06
Primary Completion 2027-06 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-15